Crossover Study to Compare PK of Once Daily LCP-Tacro Tablets to Generic Tacrolimus Capsules Twice Daily.
Status:
Completed
Trial end date:
2015-08-01
Target enrollment:
Participant gender:
Summary
Open label, prospective, single-center, randomized, two sequence, three period crossover
study to compare the steady state pharmacokinetics of LCP-Tacro tables to generic tacrolimus
capsules administered twice daily in stable African-American renal transplant patients.